BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 12767108)

  • 1. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms.
    Cleeland CS; Bennett GJ; Dantzer R; Dougherty PM; Dunn AJ; Meyers CA; Miller AH; Payne R; Reuben JM; Wang XS; Lee BN
    Cancer; 2003 Jun; 97(11):2919-25. PubMed ID: 12767108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms.
    Myers JS
    Oncol Nurs Forum; 2008 Sep; 35(5):802-7. PubMed ID: 18765326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms.
    Lee BN; Dantzer R; Langley KE; Bennett GJ; Dougherty PM; Dunn AJ; Meyers CA; Miller AH; Payne R; Reuben JM; Wang XS; Cleeland CS
    Neuroimmunomodulation; 2004; 11(5):279-92. PubMed ID: 15316238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia.
    De La Garza R
    Neurosci Biobehav Rev; 2005; 29(4-5):761-70. PubMed ID: 15878621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms.
    Wood LJ; Nail LM; Perrin NA; Elsea CR; Fischer A; Druker BJ
    Biol Res Nurs; 2006 Oct; 8(2):157-69. PubMed ID: 17003255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines as mediators of depression: what can we learn from animal studies?
    Dunn AJ; Swiergiel AH; de Beaurepaire R
    Neurosci Biobehav Rev; 2005; 29(4-5):891-909. PubMed ID: 15885777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines.
    Wood LJ; Nail LM; Gilster A; Winters KA; Elsea CR
    Oncol Nurs Forum; 2006 May; 33(3):535-42. PubMed ID: 16676010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.
    Gold SM; Irwin MR
    Neurol Clin; 2006 Aug; 24(3):507-19. PubMed ID: 16877121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a biological basis for the clustering of symptoms?
    Miaskowski C; Aouizerat BE
    Semin Oncol Nurs; 2007 May; 23(2):99-105. PubMed ID: 17512436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elusive concept of the symptom cluster.
    Barsevick AM
    Oncol Nurs Forum; 2007 Sep; 34(5):971-80. PubMed ID: 17878126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin.
    Tohmi M; Tsuda N; Watanabe Y; Kakita A; Nawa H
    Neurosci Res; 2004 Sep; 50(1):67-75. PubMed ID: 15288500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-induced sickness behavior: where do we stand?
    Dantzer R
    Brain Behav Immun; 2001 Mar; 15(1):7-24. PubMed ID: 11259077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Symptom clusters in cancer patients].
    Yang CH; Chen ML
    Hu Li Za Zhi; 2008 Apr; 55(2):22-8. PubMed ID: 18393206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodologic issues in the measurement of cytokines to elucidate the biological basis for cancer symptoms.
    Gilbertson-White S; Aouizerat BE; Miaskowski C
    Biol Res Nurs; 2011 Jan; 13(1):15-24. PubMed ID: 20798153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment.
    Myers JS; Pierce J; Pazdernik T
    Oncol Nurs Forum; 2008 Nov; 35(6):916-20. PubMed ID: 18980922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide.
    Deak T; Bellamy C; D'Agostino LG; Rosanoff M; McElderry NK; Bordner KA
    Behav Brain Res; 2005 May; 160(1):125-34. PubMed ID: 15836907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom management in the elderly cancer patient: fatigue, pain, and depression.
    Rao A; Cohen HJ
    J Natl Cancer Inst Monogr; 2004; (32):150-7. PubMed ID: 15263059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.